Growth Metrics

Cresco Labs (CRLBF) Total Non-Current Liabilities (2019 - 2026)

Cresco Labs filings provide 8 years of Total Non-Current Liabilities readings, the most recent being $856.5 million for Q1 2026.

  • On a quarterly basis, Total Non-Current Liabilities fell 2.15% to $856.5 million in Q1 2026 year-over-year; TTM through Mar 2026 was $856.5 million, a 2.15% decrease, with the full-year FY2025 number at $844.6 million, down 3.23% from a year prior.
  • Total Non-Current Liabilities hit $856.5 million in Q1 2026 for Cresco Labs, up from $844.6 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $885.5 million in Q2 2025 to a low of $689.2 million in Q2 2022.
  • Median Total Non-Current Liabilities over the past 5 years was $740.1 million (2022), compared with a mean of $784.0 million.
  • Biggest five-year swings in Total Non-Current Liabilities: skyrocketed 64.23% in 2022 and later decreased 3.23% in 2025.
  • Cresco Labs' Total Non-Current Liabilities stood at $740.1 million in 2022, then fell by 1.35% to $730.2 million in 2023, then rose by 19.54% to $872.8 million in 2024, then fell by 3.23% to $844.6 million in 2025, then rose by 1.4% to $856.5 million in 2026.
  • The last three reported values for Total Non-Current Liabilities were $856.5 million (Q1 2026), $844.6 million (Q4 2025), and $842.8 million (Q3 2025) per Business Quant data.